Associated Press
June 29, 2005
WASHINGTON -- The government is planning to strengthen warnings about possible psychiatric side effects from Concerta and related treatments for attention deficit hyperactivity, and is probing whether other ADHD drugs need updating, too.
Concerta is a long-acting form of methylphenidate, sold generically and under the brand name Ritalin. For years, those drugs' labels have listed possible psychiatric side effects, such as agitation, psychosis or transient depression.
Full article available at:
http://www.nynewsday.com/news/nationworld/politics/wire/sns-ap-attention-deficit-drugs,0,5084531,print.story
For more information and resources on autism, go to: http://www.autismconcepts.com/.